US 9328387
Antipsychotic treatment based on SNP genotype
granted A61KA61K31/454A61P
Quick answer
US patent 9328387 (Antipsychotic treatment based on SNP genotype) held by VANDA PHARMACEUTICALS INC. expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/454, A61P, A61P25/18